GLUE Competitors & Alternatives
Compare Monte Rosa Therapeutics Inc with similar stocks in the same industry
Biotechnology
GLUE
Main Stock$10.50
Tradestie Score
42
Market Cap
$463.20M
Revenue Growth
-0.6%
Analyst Upside
+171.4%
Top Competitors
229 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
IMTX
Immatics N.V. Ordinary Shares
|
$7.59
|
$1.09B | - | 40 | Compare |
|
PHAR
Pharming Group N.V. ADS, each representing 10 ordinary shares
|
$9.75
|
$1.05B | 71.4 | 43 | Compare |
|
ANL
ANL
|
$15.09
|
$1.03B | - | 49 | Compare |
|
MDXG
MiMedx Group, Inc
|
$4.59
|
$1.01B | 116.5 | 42 | Compare |
|
PRME
Prime Medicine, Inc. Common Stock
|
$2.98
|
$996.55M | - | 64 | Compare |
|
SYRE
Spyre Therapeutics, Inc. Common Stock
|
$93.19
|
$994.20M | - | 56 | Compare |
|
VALN
Valneva SE American Depositary Shares
|
$5.74
|
$993.46M | - | 53 | Compare |
|
IMNM
Immunome, Inc.
|
$20.90
|
$987.09M | - | 59 | Compare |
|
SANA
Sana Biotechnology, Inc. Common Stock
|
$2.89
|
$951.83M | - | 58 | Compare |
|
MNMD
Mind Medicine (MindMed) Inc. Common Shares
|
$15.02
|
$938.16M | - | 43 | Compare |
More GLUE Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2836)
229 stocks in this industry